Strabistmus. Unspecified strabismus
Conditions
Interventions
Intervention 1: Intervention group 1: The patients in the group one receive 0.75mg/kg intravenous midazolam after the beginning of the anesthesia . Intervention 2: Intervention group 2: Patients in gr
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 62 Years
Inclusion criteria
Inclusion criteria: ASA I-II Candidate for strabismus surgery Age between 18-62 years The desire to participate in the study
Exclusion criteria
Exclusion criteria: Patient with motion sickness disease Receiving an anti-emetic drug in the last 24 hours Patient being treated with opioid Pregnant women smokers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity and frequency of nausea and vomiting. Timepoint: 0-2 and 2-24 hours after surgery. Method of measurement: Calculating nausea-vomiting frequency by questionnaire and nausea-vomiting intensity by Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain frequency. Timepoint: 1)First 0-2 hours 2) first 2-24 hours. Method of measurement: questionnaire.;Pain intensity. Timepoint: 1)first 0-2 hours 2)first 2-24 hours. Method of measurement: Visual analogue scale.;Time of extubation. Timepoint: After the end of the surgery. Method of measurement: A Period between end of the surgery and extubation measured By anesthesiologist.;Recovery time. Timepoint: After the end of the surgery. Method of measurement: A period between the end of the surgery and going to the ward that is measured by modified aldrete score.;Patient satisfaction. Timepoint: At the time of the patient discharge. Method of measurement: Likert scale.;Time of eating and drinking. Timepoint: After the end of the surgery. Method of measurement: The first time of eating and drinking After the surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidreza Shetabi
Esfahan University of Medical Sciences
Outcome results
None listed